You searched for "clinics"
Orbis and Heidelberg Engineering team up on free e-learning opportunities
Sight-saving charity Orbis and high-tech imaging and data solutions company Heidelberg Engineering are leveraging technology to provide free clinical education for eye care professionals around the world.Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...Moorfields implementing a non-medical intravitreal injection service
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...Moorfields: Implementing a non-medical intravitreal injection service
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...Moorfields: Implementing a non-medical intravitreal injection service Nov
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services.
Diagnosis of ocular tuberculosis
This review article provides an update on the methods diagnosing ocular tuberculosis (TB), the difficulties in making the diagnosis and makes recommendations to a more accurate diagnosis by combining the available diagnostic tests. Today ocular TB remains a presumptive clinical...The fragile p-value
Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...Learning from litigation: ocular drug toxicity
Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the sword of Damocles above us...Study shows laser treatment could significantly improve treatment for glaucoma in Africa
Results of a trial published in Lancet Global Health on 14/10/21 could pave the way for significant improvements in treatment for glaucoma in Sub-Saharan Africa.CHEC and Royal National Institute for Blind People Launch Strategic Partnership
CHEC has today announced the launch of a new partnership with the Royal National Institute of Blind People.
